Related references
Note: Only part of the references are listed.STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner et al.
GASTROENTEROLOGY (2021)
Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis
Christopher Ma et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis
Neeraj Narula et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC
Jean-Frederic Colombel et al.
GUT (2017)
Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials
V. Jairath et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
Simon P. L. Travis et al.
GUT (2012)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis
K Geboes et al.
GUT (2000)
Share Paper
